Ultragenyx Pharmaceutical Inc. (RARE) Earnings
NASDAQ·Healthcare·Biotechnology
$14.37
-0.28%
Mkt Cap $1.51B
EPS — Estimate vs Actual
Mkt Cap
$1.51B
P/E
—
Fwd P/E
—
P/S
2.25
Rev TTM
—
EPS TTM
-$6.11
NASDAQ·Healthcare·Biotechnology
$14.37
-0.28%
Mkt Cap $1.51B
Mkt Cap
$1.51B
P/E
—
Fwd P/E
—
P/S
2.25
Rev TTM
—
EPS TTM
-$6.11